Rating History for Arbutus Biopharma (ABUS) by Jefferies

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/2/2022 Dennis Ding Upgrade Buy
(Hold)
5.00
(4.00)
2.81
(4.35)
54.8% Details